Droxidopa Capsule
FDA Label NDC 70771-1609

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Droxidopa (NDC 70771-1609). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1609-9

Droxidopa Capsules, 100 mg

90 Capsules

Rx only

Droxi-100mg-image (6eb3b204 C7b2 470e B168 37fef59fa63f 01)

Droxi-100mg-image (6eb3b204 C7b2 470e B168 37fef59fa63f 01)

NDC 70771-1610-9

Droxidopa Capsules, 200 mg

90 Capsules

Rx only

Droxi-200mg-image (6eb3b204 C7b2 470e B168 37fef59fa63f 02)

Droxi-200mg-image (6eb3b204 C7b2 470e B168 37fef59fa63f 02)

NDC 70771-1611-9

Droxidopa Capsules, 300 mg

90 Capsules

Rx only

Droxi-300mg-image (6eb3b204 C7b2 470e B168 37fef59fa63f 03)

Droxi-300mg-image (6eb3b204 C7b2 470e B168 37fef59fa63f 03)

* Please review the disclaimer below.